AllSight
Companies · EYE · Ophthalmic Goods · Earnings · Aug 12, 2026

The sales engine softened—but margin expansion forced a guidance raise

Beatpartly known
Adjusted diluted EPS $0.25 vs ~$0.18 published Q2 estimate
National Vision Holdings, Inc. (EYE) — what happened, in plain English, and what it means versus what the market expected.

The cleanest market benchmark was beaten. Adjusted diluted EPS was $0.25 versus a published Q2 estimate of roughly $0.18, while GAAP diluted EPS was $0.15 versus $0.11 a year earlier (Adjusted Diluted EPS reconciliation; Income Statement).

MetricQ2 2026Q2 2025 / expectationRead
Net revenue$498.8M$486.4M prior year+2.5% (Financial Highlights; Income Statement)
Adjusted comparable-store sales2.2%3.0%-5.0% FY2026 outlookBelow company target (Comparable Store Sales reconciliation)
Adjusted operating income$31.6M$23.8M prior year+32.7% (Adjusted Operating Income reconciliation)
Adjusted operating margin6.3%4.9% prior year+140 bps (Adjusted Operating Income reconciliation)
Adjusted diluted EPS$0.25~$0.18 published estimateBeat (Adjusted Diluted EPS reconciliation)
FY2026 adjusted operating income guide$119M-$139M$107M-$133M prior guideRaised (Fiscal 2026 Outlook)
FY2026 adjusted diluted EPS guide$0.94-$1.09$0.85-$1.09 prior guideFloor raised; ceiling unchanged (Fiscal 2026 Outlook)

The underlying sales trend was weaker than the headline revenue suggests. Reported comparable-store sales rose 3.4%, but the company’s adjusted measure was only 2.2% after removing the benefit from unearned and deferred revenue; that fell below the prior 3.0%-6.0% full-year range and below the updated 3.0%-5.0% range (Comparable Store Sales reconciliation). Lower self-pay traffic and declines at Military and Fred Meyer locations remain the pressure points (Financial Highlights).

Margins, not demand, drove the upgrade. Adjusted operating income rose to $31.6 million, helped by lower SG&A and a 200-basis-point decline in SG&A as a percentage of revenue to 48.8% (Financial Highlights; Adjusted SG&A reconciliation). But costs applicable to revenue increased faster than sales, lifting that ratio by 60 basis points to 41.8% as the mix shifted toward higher-value products (Financial Highlights). The company also said the timing of unearned revenue added $2.9 million to quarterly adjusted operating income and $0.03 to adjusted EPS (Financial Highlights), so part of the quarter’s strength was timing-related rather than purely recurring.

The full-year guide is a quality upgrade, not a broad demand upgrade. Adjusted operating-income guidance increased at both ends, with the midpoint rising from $120 million to $129 million, while adjusted EPS guidance raised its floor from $0.85 to $0.94 but left the top at $1.09 (Fiscal 2026 Outlook). In contrast, the comparable-sales ceiling fell from 6.0% to 5.0% and the revenue range narrowed slightly lower at the midpoint (Fiscal 2026 Outlook). That combination says management sees more confidence in cost control and profitability than in near-term traffic growth.

Cash generation and buybacks add support but do not erase the demand caveat. Operating cash flow was $69.8 million for the first six months versus $86.5 million a year earlier, while inventory increased to $122.6 million from $89.3 million at year-end (Cash Flow statement; Balance Sheet). The company repurchased about 1.2 million shares for $20 million during the quarter, with $30 million remaining under authorization (Financial Highlights). Net: a genuine adjusted-EPS beat and a meaningful margin-led guidance raise, but against softer-than-target comparable sales and some favorable revenue timing—best characterized as a narrow beat rather than a clean acceleration.

Read the original 8-K on SEC EDGAR ↗
All EYE filings, decoded →
Related companies in Ophthalmic Goods
Latest across the market
FLOCFlowco acquisition adds Canadian rod lift but increases debt-funded execution riskSSBSouthState schedules Q3 earnings for Oct. 21, with no new signalPSKYParamount Skydance changes ticker to SKYD as NYSE listing and warrants nearCTRECareTrust acquisition adds 45 UK care homes, but SHOP payoff is years awayUMHUMH earnings update shows 28% home-sales growth as occupancy keeps improvingNTSTNETSTREIT debt amendment formalizes investment-grade pricing and widens leverage cushionBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact